{"organizations": [], "uuid": "846fd6257475203bb13dcc2921205033f2c2e5c0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-abbvie-inc-reports-q1-gaap-earning/brief-abbvie-inc-reports-q1-gaap-earnings-per-share-of-1-74-idUSB8N1HP02E", "country": "US", "domain_rank": 408, "title": "BRIEF-Abbvie Inc Reports Q1 GAAP Earnings Per Share Of $1.74", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-26T14:49:00.000+03:00", "replies_count": 0, "uuid": "846fd6257475203bb13dcc2921205033f2c2e5c0"}, "author": "", "url": "https://www.reuters.com/article/brief-abbvie-inc-reports-q1-gaap-earning/brief-abbvie-inc-reports-q1-gaap-earnings-per-share-of-1-74-idUSB8N1HP02E", "ord_in_thread": 0, "title": "BRIEF-Abbvie Inc Reports Q1 GAAP Earnings Per Share Of $1.74", "locations": [], "entities": {"persons": [], "locations": [{"name": "humira", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "brief-abbvie inc", "sentiment": "negative"}, {"name": "abbvie inc", "sentiment": "none"}, {"name": "gaap", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 26 (Reuters) - AbbVie Inc:\n* QUARTERLY ADJUSTED EARNINGS PER SHARE $1.87 * QUARTERLY WORLDWIDE NET REVENUE $7.93 BILLION, UP 21.4 PERCENT ON GAAP BASIS\n* Q1 EARNINGS PER SHARE VIEW $1.79, REVENUE VIEW $7.59 BILLION — THOMSON REUTERS I/B/E/S\n* QUARTERLY GLOBAL HUMIRA SALES $4.71 BILLION, UP 14.4 PERCENT ON REPORTED BASIS\n* QUARTERLY GLOBAL IMBRUVICA NET REVENUE $762 MILLION, UP 38.5 PERCENT\n* UPDATES 2018 GAAP EARNINGS PER SHARE OUTLOOK TO $6.82-$6.92\n* RAISES 2018 ADJUSTED EARNINGS PER SHARE OUTLOOK TO $7.66-$7.76 FROM $7.33-$7.43\n* FY2018 EARNINGS PER SHARE VIEW $7.55 — THOMSON REUTERS I/B/E/S\n* ANNOUNCES INTENTION TO COMMENCE SELF-TENDER OFFER FOR UP TO $7.5 BILLION OF COMMON STOCK\n* THURSDAY’S TENDER OFFER FORMS PART OF $10 BILLION STOCK REPURCHASE PROGRAM ANNOUNCED ON FEB 15, 2018\n* SAYS 2018 ADJUSTED EARNINGS PER SHARE OUTLOOK REFLECTS EFFECTIVE TAX RATE APPROACHING 9 PERCENT IN 2018\n* IN 2018, WILL EXPERIENCE ONE-TIME NET TAX BENEFIT RELATED TO TIMING OF PHASE IN OF PROVISIONS OF NEW LEGISLATION ON CERTAIN SUBSIDIARIES Source text for Eikon:\n ", "external_links": [], "published": "2018-04-26T14:49:00.000+03:00", "crawled": "2018-04-26T15:04:18.016+03:00", "highlightTitle": ""}